Illumina Partners with Broad Clinical Labs for Single-Cell Sequencing

Illumina, a global leader in next-generation sequencing and array-based technologies, has entered into a partnership with Broad Clinical Labs to develop scalable single-cell sequencing technologies.

Partnership Details

The collaboration aims to create a 5 billion cell atlas within three years. This project will enable researchers to process and analyze vast amounts of single-cell data with unprecedented speed and accuracy.

Goals and Objectives

The partnership seeks to accelerate discovery in areas such as disease modeling and drug development. This breakthrough is expected to set a new standard for scalable studies in the field of single-cell research.

Key Highlights

• The partnership will focus on developing next-generation single-cell sequencing methods
• The goal is to create a 5 billion cell atlas within three years
• The collaboration aims to enable researchers to process and analyze vast amounts of single-cell data with unprecedented speed and accuracy